Showing results (101-110 of 373) with videos related to
Sort By:
Pageof 38
Clinical Pharmacokinetics|November 1, 1984
Interactions and non-interactions with ranitidineW Kirch, H Hoensch, H D JanischJournal of Clinical Pharmacology|December 1, 1990
Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patientsW Kirch, H J Hutt, V PlänitzBrain Research|May 29, 1995
Immunohistochemical localization of neuropeptides in the human ciliary ganglionW Kirch, W Neuhuber, E R TammJournal of Cardiovascular Pharmacology|June 1, 1995
Hemolysis on intravenous administration of a new calcium antagonistC H Kleinbloesem, M Siepmann, W KirchJournal of Human Hypertension|October 23, 1997
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairmentD de Zeeuw, G Remuzzi, W KirchEuropean Journal of Clinical Investigation|October 10, 1998
Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteersM Grossmann, M J Jamieson, W KirchClinical Drug Investigation|August 14, 2016
Disposition, Elimination and Haemodynamic Effects of Gallopamil in Patients with Fatty Liver DiseaseM Siepmann, B R Rao, W KirchFortschritte Der Medizin. Originalien|May 1, 2004
[Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients]S K Hildemann, H M Fischer, D Pittrow, et al.Pneumologie (Stuttgart, Germany)|June 26, 2013
[Early diagnosis and therapy in pulmonary hypertension--aspects of a vision]R Ewert, H Olschewski, H A Ghofrani, et al.Journal of Chromatography. A|July 2, 2003
Increasing sample throughput in pharmacological studies by using dual-column liquid chromatography with tandem mass spectrometryR Oertel, K Richter, J Fauler, et al.Pageof 38